LINCS gene expression signatures analysis revealed bosutinib as a radiosensitizer of breast cancer cells by targeting <i>eIF4G1</i>

Sai Hu(Beijing Radiation Center), Hua Guan(Beijing Radiation Center)
bioRxiv (Cold Spring Harbor Laboratory)
April 24, 2020
Cited by 2


Related Papers